3-rx.comCustomer Support
HomeAbout UsFAQContactHelp
News Center
Health Centers
Medical Encyclopedia
Drugs & Medications
Diseases & Conditions
Medical Symptoms
Med. Tests & Exams
Surgery & Procedures
Injuries & Wounds
Diet & Nutrition
Special Topics

\"$alt_text\"');"); } else { echo"\"$alt_text\""; } ?>

You are here : 3-RX.com > Drugs & Medications > Detailed Drug Information (USP DI) > Ibritumomab Tiuxetan

Ibritumomab Tiuxetan (Systemic)

Brand Names : Zevalin, IDEC-2B8 (ibritumomab tiuxetan), IDEC-Y2B8 (yttrium-90–ibritumomab tiuxetan), IDEC-In2B8 (indium-111–ibritumomab tiuxetan), IDEC-129

Description and Brand Names | Before Using | Proper Use | Precautions | Side Effects

  • Monoclonal antibody
  • antineoplastic (radioactive)

Ibritumomab Tiuxetan (ib-ri-TU-moe-mab) (tie-ux-EH-tan) is a protein called a monoclonal antibody. It is used along with another monoclonal antibody (rituximab) and two radioactive pharmaceuticals (In-111 and Y-90). Ibritumomab tiuxetan is used to treat a type of cancer called non-Hodgkin's lymphoma.

Ibritumomab Tiuxetan is to be administered only by or under the immediate supervision of your doctor. It is available in the following dosage form:

  • Injection (U.S.)

Brand Names

Some commonly used brand names are:

In the U.S. -

  • Zevalin

Other commonly used names are:

  • IDEC-2B8 (ibritumomab tiuxetan)
  • IDEC-Y2B8 (yttrium-90-ibritumomab tiuxetan)
  • IDEC-In2B8 (indium-111-ibritumomab tiuxetan)
  • IDEC-129

† Not commercially available in Canada.


Next section


Ibritumomab Tiuxetan: Before Using

\"$alt_text\"');"); } else { echo"\"$alt_text\""; } ?>

Home | About Us | FAQ | Contact | Advertising Policy | Privacy Policy | Bookmark Site